1 min to read News Posted on May 5, 2023 FDA Guidance Clarifies Approach to Decentralized Clinical Trials – Ropes & Gray LLP FDA Guidance Clarifies Approach to Decentralized Clinical Trials Source: FDA Guidance Clarifies Approach to Decentralized Clinical Trials – Ropes & Gray LLP share tweet share SPACs: Are You Really Ready To Commit?Why Buy a SPAC Before It Identifies a Target?By the Numbers: Four Practices Big Law Firms Need to Power 2023 – Bloomberg LawReport: SPACs and De-SPACing: Considerations for Going Public Through a Combination with a SPAC Tags: SPACs